Real-time enrollment status for this iga nephropathy clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 5:52 AM UTC
| NCT Number | NCT06935357 |
| Recruiting Status | Recruiting |
| Condition | IgA Nephropathy |
| Phase | PHASE3 |
| Target Enrollment | 454 participants |
| Active Locations | 29 sites in the US |
| Sponsor | Biogen |
| Last Updated on CT.gov | October 14, 2026 (Yesterday) |
As of October 15, 2026: Clinical trial NCT06935357 is currently recruiting participants. This phase3 study for iga nephropathy is actively seeking new participants at 29 locations across the United States. The study is sponsored by Biogen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06935357 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06935357 was last updated Yesterday (October 14, 2026). HelloStudys verifies this status automatically.